Biopharmaceuticals

#AI / data analytics / healthtech / informatics #Biopharmaceuticals #Drug discovery #Healthcare

How AI in pharma can live up to the hype 

Listen to this article on the DDW Podcast: Ben Folwell, Principal Consultant at Citeline, maps out how AI, swarm learning and open access to clinical data could revolutionise drug discovery.  Artificial intelligence (AI) is notorious for its industry hype, touted to revolutionise the way multiple sectors… Read More

#Business & Investment #Exclusive Content #Opinion #Trends & Analysis

Medical researchers
#Biopharmaceuticals #Drug discovery #Start-ups #Venture Lab

More start-ups join Venture Lab programme

The latest cohort of companies have joined the Venture Lab acceleration programme for early-stage companies, created by non-profit foundation the BioInnovation Institute (BII). Designed to help build research-based ideas with high-growth commercial potential into viable start-ups, BII’s 12-month Venture Lab programme supports business acceleration, scientific and team development. It provides… Read More

#News #Start-up Zone

#Advanced Therapies #Biopharmaceuticals #Drug development

Leveraging education to close the advanced therapy talent gap 

Tony Khoury, Executive Vice President of Project Farma and Anshul Mangal, President & General Counsel of Project Farma, share how the industry is leveraging stronger education programmes to close the advanced therapy talent gap.  The cell and gene therapy industry has experienced exponential growth in the last three years… Read More

#Exclusive Content

#Biopharmaceuticals #Japan #Pharma Awards

Awards success for Sosei Heptares

Biopharmaceutical company Sosei Group received both Licensing Deal of the Year and Executive of the Year at the first Informa Pharma Intelligence Awards Japan. The Informa Pharma Intelligence Awards Japan recognise outstanding innovations in Japanese pharma and biotech. The categories were judged by a panel of industry experts within academia… Read More

#News

#Assays #Biopharmaceuticals #Biotherapeutics #Drug development #Drug discovery

PerkinElmer releases assay kits for more effective biotherapeutics 

PerkinElmer has announced two ready-to-use HTRF and AlphaLISA no-wash assay kits designed to quickly and easily detect and quantify CHO HCP impurities during biopharmaceutical manufacturing.   Recombinant therapeutic proteins, such as monoclonal antibodies, some vaccines and other biologics, must be free of residual host cell protein (HCP) impurities… Read More

#News

#Awards #Biopharmaceuticals #R&D

Global R&D challenge to accelerate scientific discovery and diversity

AstraZeneca has launched a global R&D Postdoctoral Challenge to help accelerate ideas to transform the treatment of some of the world’s most complex diseases. Successful proposals will secure fully funded postdoctoral research positions. The challenge The challenge, launched at EXPO 2020 Dubai, invites final year MD and/or PhD students and… Read More

#News

#Biopharmaceuticals #Covid-19

Needle-free intranasal Covid-19 vaccine gets green-light for trials 

Oragenics has entered into an agreement with KBI Biopharma for the process transfer, process optimisation and cGMP manufacturing of the company’s intranasal vaccine candidate NT-CoV2-1, which is expressed in a proprietary CHO cell line.   Background  Oragenics previously demonstrated robust immune response and reduction of SARS-CoV-2… Read More

#News #Trending News

#Biopharmaceuticals #Biotherapeutics #Drug development

Successful discovery and development collaboration continues  

Thermo Fisher Scientific and Symphogen are continuing their collaboration to provide biopharmaceutical discovery and development laboratories with innovative tools and streamlined workflows for efficient characterisation of complex therapeutic proteins.   Since the collaboration began in 2018, Symphogen has adopted instruments and software to improve data quality and processes… Read More

#News

#Biopharmaceuticals #Covid-19 #Drug discovery #Pharmaceutical #Therapeutics #Women in STEM

International Women’s Day: Female achievement in drug discovery

The theme for International Women’s Day 2022 is ‘Break the Bias’, in which society is encouraged to celebrate women’s achievements, in turn raising awareness against bias and inspiring positive action for equality. Though the initiative is interdisciplinary, the drug discovery, life science and pharmaceutical world boasts many achievements of this… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trending News

#ATMP #Biopharmaceuticals #Regulatory

Five marketing strategies for ATMPs 

The advanced therapy medicinal products (ATMPs) sector holds great promise. However, multidisciplinary strategies that begin early in the development process should be adopted, says Christian Schneider, head of Biopharma Excellence and Chief Medical Officer at PharmaLex. He outlines five strategies for avoiding pitfalls and boosting the success rates of… Read More

#Editor's Choice #Intelligence #News #Opinion #Regulatory #Trends & Analysis

#Biopharmaceuticals #Drug development #Drug innovation #Funding

Key take-aways from new R&D trends report 

As the global Covid-19 pandemic enters its third year, the life sciences innovation system is setting new records in the level of investment, activity, and scientific progress, according to the IQVIA Institute. In its report, Global Trends in R&D: Overview through 2021, the IQVIA assesses the trends… Read More

#News #Trends & Analysis

#AI / data analytics / healthtech / informatics #Bioinformatics #Biopharmaceuticals #Biotechnology #Collaboration

Scitara joins collaboration to drive biopharmaceutical advancements  

Scitara has become a member of BioPhorum, a global community that enables collaboration throughout the biopharmaceutical industry with the goal of accelerating scientific advancements.  The Lab of the Future  Scitara joins BioPhorum Information Technology, which aims to accelerate digital maturity across the global biomanufacturing industry. One of the programmes within the portfolio,… Read More

#News

#Biopharmaceuticals #Drug discovery #R&D #Therapeutics

Sitting down with… Dr Michael Hayden, Prilenia Therapeutics

Listen to this article on the DDW Podcast: Dr Michael Hayden’s early encounters and experience with patients and families suffering from Huntington’s Disease has had a significant personal impact that shaped his career. As CEO of Prilenia Therapeutics, he tells Lu Rahman why he has dedicated his career… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#Biomarkers #Biopharmaceuticals #Biotechnology #Funding

€13.5m financing round to accelerate proteomics tools and consumables 

PreOmics has raised €13.5 million in a Series B financing round provided by Bruker Corporation, which is expected to broaden the market opportunities for both PreOmics’ platform technologies and Bruker’s  proteomics platform with more complete, automated workflow solutions for academic and clinical researchers, for biomarker discovery and diagnostics companies, as well as for… Read More

#News

#Biopharmaceuticals #Pharmaceutical research #Screening

Catalyst screening service offers accelerated route to market 

China-based Sinocompound Catalysts has partnered with InCatT to launch a specialist Catalyst Screening Service for pharmaceutical and fine chemical companies looking to optimise their reactions.   The service  The new service draws on InCatT’s experience in screening homogeneous catalysts combined with Sinocompound’s expertise in custom synthesis, scale-up and manufacturing of advanced catalysts and ligands. By combining… Read More

#News

#Biopharmaceuticals #Biotherapeutics #Clinical trials

4D Pharma announces positive topline results for the treatment of asthma 

4D Pharma has announced positive topline results from Part A of its Phase I/II clinical trial of MRx-4DP0004, an orally-delivered single strain Live Biotherapeutic being developed for the treatment of asthma.  Part A  The Phase I/II trial is a multi-center, double-blind, placebo-controlled study in patients… Read More

#News